Literature DB >> 24722787

Targeted pre-operative autologous blood donation: a prospective study of two thousand and three hundred and fifty total hip arthroplasties.

Jad Bou Monsef1, Mark P Figgie, David Mayman, Friedrich Boettner.   

Abstract

PURPOSE: Pre-operative donation of autologous blood has been widely used in elective joint replacement procedures to avoid the risks of allogeneic blood transfusions. However, the high percentage of wasted autologous blood questions the general efficacy of pre-operative autologous blood donation (PABD) for all patients undergoing hip replacement. This study prospectively investigates the impact of a targeted pre-operative autologous blood donation protocol for anaemic patients on allogeneic and overall transfusion rates in 2,350 unilateral primary total hip arthroplasty procedures.
METHODS: Patients with pre-operative haemoglobin less than 12.5 g/dL were advised to donate one unit of autologous blood seven to 15 days prior to the date of surgery. The targeted protocol was followed by 2,251 patients: 280 out of 367 anaemic patients donated while 1,971 out of 1,983 non-anaemic patients did not donate.
RESULTS: Results showed a significantly lower rate of allogeneic transfusion for anaemic patients who predonated than anaemic patients who did not (13 % vs. 37% respectively, p < 0.001). Overall transfusion rates for patients who followed the protocol (n = 2,251) were found to be 0.17 units/patient compared to previously reported numbers of 0.75 units/patient when routine donation was used. Among the 2,251 patients who followed the protocol, only 140 patients (6%) had their autologous blood wasted, in contrast to values reported in the literature ranging from 14% up to 50%.
CONCLUSIONS: Targeted PABD reduces the need for allogeneic blood transfusion in anaemic patients and significantly reduces the overall number of transfusions compared to routine pre-operative autologous donation.

Entities:  

Mesh:

Year:  2014        PMID: 24722787      PMCID: PMC4115105          DOI: 10.1007/s00264-014-2339-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  22 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

Review 2.  Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations.

Authors:  M Muñoz; J A García-Erce; I Villar; D Thomas
Journal:  Vox Sang       Date:  2009-01       Impact factor: 2.144

3.  Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study.

Authors:  Aditya K Aggarwal; V S Shashikanth; Neelam Marwaha
Journal:  Int Orthop       Date:  2013-10-11       Impact factor: 3.075

4.  Who needs autologous blood donation in joint replacement?

Authors:  Javad Parvizi; Sonia Chaudhry; Mohammad R Rasouli; Luis Pulido; Ashish Joshi; Jay H Herman; Richard H Rothman
Journal:  J Knee Surg       Date:  2011-03       Impact factor: 2.757

5.  Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.

Authors:  Melita Buljan; Damir Nemet; Branka Golubic-Cepulic; Goran Bicanic; Branko Tripkovic; Domagoj Delimar
Journal:  Int Orthop       Date:  2011-10-01       Impact factor: 3.075

6.  Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.

Authors:  Erik T Newman; Tyler Steven Watters; John S Lewis; Jason M Jennings; Samuel S Wellman; David E Attarian; Stuart A Grant; Cynthia L Green; Thomas P Vail; Michael P Bolognesi
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

7.  A prospective, randomized study of preoperative autologous donation for hip replacement surgery.

Authors:  Dinna B Billote; Silas N Glisson; David Green; Richard L Wixson
Journal:  J Bone Joint Surg Am       Date:  2002-08       Impact factor: 5.284

8.  Nonanemic patients do not benefit from autologous blood donation before total hip replacement.

Authors:  Friedrich Boettner; Eric I Altneu; Brendan A Williams; Matthew Hepinstall; Thomas P Sculco
Journal:  HSS J       Date:  2009-12-05

9.  Pre-operative autologous blood donation versus no blood donation in total knee arthroplasty: a prospective randomised trial.

Authors:  Sanja Jakovina Blazekovic; Goran Bicanic; Pero Hrabac; Branko Tripkovic; Domagoj Delimar
Journal:  Int Orthop       Date:  2013-12-05       Impact factor: 3.075

Review 10.  Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.

Authors:  D A Henry; P A Carless; A J Moxey; D O'Connell; M A Forgie; P S Wells; D Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2002
View more
  3 in total

1.  Can tranexamic acid change preoperative anemia management during total joint arthroplasty?

Authors:  Duy L Phan; Joseph B Rinehart; Ran Schwarzkopf
Journal:  World J Orthop       Date:  2015-08-18

Review 2.  Surgical Technical Evidence Review for Elective Total Joint Replacement Conducted for the AHRQ Safety Program for Improving Surgical Care and Recovery.

Authors:  Christopher P Childers; Anaar E Siletz; Emily S Singer; Claire Faltermeier; Q Lina Hu; Clifford Y Ko; Gregory J Golladay; Stephen L Kates; Elizabeth C Wick; Melinda Maggard-Gibbons
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-02-12

3.  Prospective study of preoperative autologous blood donation for patients with high risk of allogeneic blood transfusion in lumbar fusion surgery: a study protocol of a randomised controlled trial.

Authors:  Nanfang Xu; Youyu Zhang; Yun Tian; Baohua Li; Haiqin Qiao; Xiaoqing Zhang; Nan Yang; Wei Li; Chao Zhang; Weishi Li; Wei Fu
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.